Autosomal-dominant polycystic kidney disease as a risk factor for diabetes mellitus following renal transplantation

Kidney International

Volumn 67, Issue 2, 2005, Pages 714-720

  De Mattos, Angelo M ^a,b   Olyaei, Ali J ^a   Prather, Jonathan C ^a   Golconda, Muralikrishna S ^a   Barry, John M ^a   Norman, Douglas J ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

Autosomal dominant polycystic kidney; Diabetes mellitus; Transplantation

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; CYCLOSPORIN; DIURETIC AGENT; INSULIN; PREDNISONE; TACROLIMUS;

ADULT; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BODY MASS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG USE; FEMALE; GRAFT REJECTION; HEREDITY; HUMAN; KIDNEY DONOR; KIDNEY GRAFT; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OBESITY; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE;

EID: 12344333418     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.67132.x     Document Type: Article

References (23)

1. UNITED STATES RENAL DATA SYSTEM (USRDS): WWW.USRDS.org (assessed March 14, 2003)
2. WILSON PD: Polycystic kidney disease. N Engl J Med 350:151-164, 2004
3. FIELDS A, RICHARDS T, FROST E, KAYE AD: Autosomal dominant polycystic kidney disease-clinical challenges. J Anesth 17:205-218, 2003
4. SCOLARI F, VIOLA BF, GHIOOERI GM, et al: Towards the identification of (a) gene(s) for autosomal dominant medullary cystic kidney disease. J Nephrol 16:321-328, 2003
5. HUGHES J, WARD CJ, PERAL B, et al. The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat Genet 10:151-160, 1995
6. THE INTERNATIONAL POLYCYSTIC KIDNEY DISEASE CONSORTIUM: Polycystic kidney disease. The complete structure of the PKD1 gene and its protein. The International Polycystic Kidney Disease Consortium. Cell 81:289-298, 1995
7. MOCHIZUKI T, WU G, HAYASHI T, et al: PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 272:1339-1342, 1996
8. IGARASHI P, SOMLO S: Genetics and pathogenesis of polycystic kidney disease. J Am Soc Nephrol 13:2384-2398, 2002
9. MARKELL MS: Post-transplant diabetes: Incidence, relationship to choice of immunosuppressive drugs, and treatment protocol. Adv Renal Replace Ther 8:64-69, 2001
10. KASISKE BL, SNYDER JJ, GILBERTSON D, et al: Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 3:178-185, 2003
11. KOSELJ M, KOSELJ-KAJTNA M, KVEDER R, et al: Post transplant diabetes mellitus: A serious complication of immunosuppression in renal allograft recipients. Transplant Proc 34:3003-3004, 2002
12. COSIO FG, PESAVENTO TE, OSEI K, et al. Post-transplant diabetes mellitus: Increasing incidence in renal allograft recipients transplanted in recent years. Kidney Int 59:732-737, 2001
13. FRIEDMAN AN, MISKULIN DC, ROSENBERG IH, et al: Demographics and trends in overweight and obesity in patients at time of kidney transplantation. Am J Kidney Dis 41:480-487, 2003
14. COSIO FG, PESAVENTO TE, KIM S, et al: Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Kidney Int 62:1440-1446, 2002
15. ROTH D, MILGROM M, ESQUENAZI V, et al: Posttransplant hyperglycemia. Increased incidence in cyclosporine-treated renal allograft recipients. Transplantation 47:278-281, 1989
16. HJELMESAETH J, JENSSEN T, HARTMANN A: Diagnosing PTDM. Transplantation 74:579, 2002
17. HJELMESAETH J, MIDTVEDT K, JENSSEN T, et al: Insulin resistance after renal transplantation: Impact of immunosuppressive and antihypertensive therapy. Diabetes Care 24:2121-2126, 2001
18. HJELMESAETH J, HARTMANN A, KOFSTAD J, et al: Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age. Transplantation 64:979-983, 1997
19. HJELMESAETH J, HARTMANN A: Risk for post transplant diabetes mellitus with current immunosuppressive medications. Am J Kidney Dis 35:562, 2000
20. DUCLOUX D, MOTTE G, VAUTRIN P, et al: Polycystic kidney disease as a risk factor for post-transplant diabetes mellitus. Nephrol Dial Transplant 14:1244-1246, 1999
21. ALSINA J, GRINYO JM: New immunosuppressive agent: Expectations and controversies. Transplantation 75:741-742, 2003
22. LUNA B, FEINGLOS MN: Drug-induced hyperglycemia. JAMA 286:1945-1948, 2001
23. BAUM CL, THIELKE K, WESTIN E, et al: E: Predictors of weight gain and cardiovascular risk in a cohort of racially diverse kidney transplant recipients. Nutrition 18:139-146, 2002